GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Days Inventory

G.Barekat Pharm (XTEH:BRKT1) Days Inventory : 164.44 (As of Mar. 2017)


View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Days Inventory?

Days Inventory is also known as Days Sales of Inventory (DSI). G.Barekat Pharm's Average Total Inventories for the six months ended in Mar. 2017 was IRR6,877,322 Mil. G.Barekat Pharm's Cost of Goods Sold for the six months ended in Mar. 2017 was IRR15,265,441 Mil. Hence, G.Barekat Pharm's Days Inventory for the six months ended in Mar. 2017 was 82.22.

The historical rank and industry rank for G.Barekat Pharm's Days Inventory or its related term are showing as below:

XTEH:BRKT1's Days Inventory is not ranked *
in the Biotechnology industry.
Industry Median: 190.92
* Ranked among companies with meaningful Days Inventory only.

G.Barekat Pharm's Days Inventory increased from . 20 (0.00) to Mar. 2017 (164.44). It might indicate that G.Barekat Pharm's sales slowed down.

Inventory Turnover measures how fast the company turns over its inventory within a year. G.Barekat Pharm's Inventory Turnover for the six months ended in Mar. 2017 was 2.22.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. G.Barekat Pharm's Inventory-to-Revenue for the six months ended in Mar. 2017 was 0.33.


G.Barekat Pharm Days Inventory Historical Data

The historical data trend for G.Barekat Pharm's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Days Inventory Chart

G.Barekat Pharm Annual Data
Trend Mar16 Mar17
Days Inventory
- 164.44

G.Barekat Pharm Semi-Annual Data
Mar16 Mar17
Days Inventory - 164.44

Competitive Comparison of G.Barekat Pharm's Days Inventory

For the Biotechnology subindustry, G.Barekat Pharm's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


G.Barekat Pharm's Days Inventory Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Days Inventory distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Days Inventory falls into.



G.Barekat Pharm Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

G.Barekat Pharm's Days Inventory for the fiscal year that ended in Mar. 2017 is calculated as

Days Inventory (A: Mar. 2017 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Mar. 2016 ) + Total Inventories (A: Mar. 2017 )) / count ) / Cost of Goods Sold (A: Mar. 2017 )*Days in Period
=( (0 + 6877322) / 1 ) / 15265441*365
=6877322 / 15265441*365
=164.44

G.Barekat Pharm's Days Inventory for the quarter that ended in Mar. 2017 is calculated as:

Days Inventory (Q: Mar. 2017 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Mar. 2016 ) + Total Inventories (Q: Mar. 2017 )) / count ) / Cost of Goods Sold (Q: Mar. 2017 )*Days in Period
=( (0 + 6877322) / 1 ) / 15265441*365 / 2
=6877322 / 15265441*365 / 2
=82.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


G.Barekat Pharm  (XTEH:BRKT1) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

G.Barekat Pharm's Inventory Turnover for the six months ended in Mar. 2017 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

G.Barekat Pharm's Inventory to Revenue for the six months ended in Mar. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


G.Barekat Pharm Days Inventory Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Days Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.


G.Barekat Pharm (XTEH:BRKT1) Business Description

Traded in Other Exchanges
N/A
Address
No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN
G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines